Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth in Missouri
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Missouri
| Provider | Medicare | Services |
|---|---|---|
| Saettele, Megan M.D. | $110.88 | 48 |
| Severs, Frederick M.D. | $122.10 | 44 |
| Elwing, Terry M.D. | $112.88 | 42 |
| Frank, Logan M.D. | $106.33 | 34 |
| Flynt, Kelsey M.D. | $119.94 | 31 |
| Saini, Rimpi MD | $384.67 | 25 |
| Ebuoma, Lilian MD | $117.18 | 25 |
Missouri Pricing in Context
In Missouri, CPT code 19081 (Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth) carries an average Medicare payment of $136.96 — 35% below the national benchmark of $210.47. 191 providers across the state submitted claims for this procedure in 2023, performing 1.4K total services. Individual payments in MO ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Missouri is $1,123.99, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Missouri sits below the national Medicare average, commercial rates in the state may also run lower than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Skin/Integumentary Surgery procedures, the estimated commercial insurance price in Missouri lands near $373.86, with self-pay cash prices typically around $443.90. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth cost in Missouri?
The average Medicare payment for Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth in Missouri is $136.96, which is 35% below the national average of $210.47. Providers in MO typically bill $1,123.99 for this procedure.
What does Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth cost with insurance in Missouri?
With commercial insurance in Missouri, Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth costs an estimated $373.86. Without insurance, the estimated cash price is $443.90. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth in Missouri?
191 providers in Missouri billed Medicare for Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth in 2023, performing 1.4K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth cheaper in Missouri than the national average?
Yes — Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth costs 35% below the national average in Missouri. The state average Medicare payment is $136.96 compared to $210.47 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.